Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. - Wikidata - wikimedia - TriplyDB

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

http://www.wikidata.org/entity/Q35057523

about

Pathophysiology, Clinical Importance, and Management of Neurogenic Lower Urinary Tract Dysfunction Caused by Suprasacral Spinal Cord Injury Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review Urinary bladder, cystitis and nerve/urothelial interactions.Urothelial signaling.OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction - A Randomized, Double-Blind, Placebo-Controlled Study Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium.Beyond neurons: Involvement of urothelial and glial cells in bladder function.Role of Purinergic Signaling in Voiding Dysfunction.Cystitis, co-morbid disorders and associated epithelial dysfunction Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome Efficacy and safety of botulinum toxin injection for interstitial cystitis/bladder pain syndrome: a systematic review and meta-analysis.Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines Botulinum toxin type A induces changes in the chemical coding of substance P-immunoreactive dorsal root ganglia sensory neurons supplying the porcine urinary bladder Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA.Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies Purinergic signalling in the urinary tract in health and disease.Botulinum neurotoxin for pain management: insights from animal models.Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Purinergic Signalling: Therapeutic Developments.Characterizing the Bladder's Response to Onabotulinum Toxin Type A Using a Rat Model.

P2860

Q26741369-2B089D5B-B34E-44CE-BC83-48FAA524892B Q26851170-649B1465-EBBB-4BD3-9CAB-FF8AD3E73036 Q30412893-265C4D08-0212-49E8-9092-8FE22B9B7814 Q30440958-CA93482E-1914-4F20-AA42-82B3480D9317 Q30831664-4894BF35-2602-4819-8483-3352AD154729 Q33671401-3331350E-C172-48AE-A1E8-0AB625110314 Q34020404-0CDD1DDF-470D-43E9-9E86-D3802F569346 Q34973917-77349CB9-4831-4AC4-806F-5DF4C96F7EDD Q35041143-CD32BAC5-99A9-4447-9FFD-8019B559F0AD Q35737565-29C30A7E-1C26-4EAC-A3FF-8272B21CC41D Q36006813-48CFD55D-23F8-417E-84AD-D00C0E53266B Q36014422-54E92E92-3EAA-4D97-83EE-56EFE67839DF Q36329632-F1371B05-B09E-4E67-937C-200DBF01F1BE Q36573132-7B38F3E1-A94D-41D8-82B4-778F30EC5DEA Q36789948-0A9D8A10-7F56-4E59-98A3-CB50AF3F2615 Q37275119-ACC5E347-8149-4675-9A5F-79DCCC89A676 Q37620260-B32EF25F-3628-4EE2-9569-BDBE05EEBBF0 Q37954278-813E2A5B-4363-4BB4-A855-514BE8B4AAB3 Q39207459-6B360FE8-57DA-45A5-8E96-455D2ED5F264 Q42367885-C7B376FF-DA36-4666-BF60-C2FDF2369917 Q42721526-7FE4C684-C0B4-449F-A6AB-CC2ECC8D4968

P2860

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

http://www.wikidata.org/entity/Q35057523

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

@ast

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

@en

type

label

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

@ast

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

@en

prefLabel

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

@ast

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

@en

P1433

Q35057523-732289FB-7962-4B73-972B-3F34C64690BA

P1476

Q35057523-3A92D024-329F-46F4-9E03-F819C17D9076

P2093

Q35057523-16540BB7-0998-4C76-BB00-187322EF2A34

Q35057523-2E4296A7-9878-41EC-AE7D-060A3CF15BAE

Q35057523-62C6BA1D-213A-4506-A8F8-81D74A007EEB

Q35057523-6D8715EF-0486-42C3-9F32-8F0586EEC611

Q35057523-B9247A48-DC31-4988-8370-91131CE47364

Q35057523-E67B541F-5948-480F-861A-80CCEB945D4D

Q35057523-F21FE9F1-C6E3-4466-8C02-E495750A627B

P2860

Q35057523-0D973ED3-68F3-4BCE-88F1-BA4A86841019

Q35057523-0DBE2316-1AA6-4672-8C5E-FEAE9C86CB49

Q35057523-11549470-D006-4D90-8750-6D10A59C32E7

Q35057523-12DBA0FA-1C98-4C1C-856D-0B322978A22B

Q35057523-1B5F1F12-573E-4E3E-A914-6918D6738373

Q35057523-20DF4E93-F347-4E4B-A607-8AE4B4DCA9D1

Q35057523-279DA21B-61C7-44DB-88E3-946CD019D85A

Q35057523-29295256-579C-4065-9C52-94B506183145

Q35057523-2AA3BB45-63C1-47A1-80A5-ACC1858CA89F

Q35057523-36922F4E-C2A1-45A9-AE3C-11CC57BC305F

P2888

Q35057523-B523E1D7-BF40-4695-87B4-24B85389D1A8

P304

Q35057523-2AD35C15-E3DC-41C4-8E14-3320BB21D782

P31

Q35057523-BCB1CB7A-CD28-4BFB-B350-B5A5513C7400

P356

Q35057523-B0674514-FB51-4E55-ADB4-3E8DD87995D9

P407

Q35057523-B83E08D8-FDCB-471E-984E-B5588690B317

P433

Q35057523-A3432F58-5397-4D82-96E6-B895278CB022

P478

Q35057523-5666AA3C-0C71-449B-9CE5-85B617B17791

P577

Q35057523-4259E847-048F-4F01-9F67-EFFB43E3C67C

P5875

Q35057523-D3E31A88-9D4E-452D-A0EF-D0C943E330E3

P698

Q35057523-75202930-B3AD-4864-A119-66F7D91655EA

P932

Q35057523-88D0355F-C216-4C8E-A8EC-77420FB0FA1A

P356

P1433

Nature Reviews Urology

P1476

Drug Insight: biological effects of botulinum toxin A in the lower urinary tract.

@en

P2093

Apostolos Apostolidis

http://www.w3.org/2001/XMLSchema#string

Christopher P Smith

http://www.w3.org/2001/XMLSchema#string

Clare J Fowler

http://www.w3.org/2001/XMLSchema#string

George T Somogyi

http://www.w3.org/2001/XMLSchema#string

K Roger Aoki

http://www.w3.org/2001/XMLSchema#string

Michael B Chancellor

http://www.w3.org/2001/XMLSchema#string

William C de Groat

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of botulinum neurotoxin type A and implications for toxicity

Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia

Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions

Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity

The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

Botulinum and tetanus neurotoxins: structure, function and therapeutic utility

Mechanisms of Disease: the role of nerve growth factor in the pathophysiology of bladder disorders.

Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.

Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity

Substance P: transmitter of nociception (Minireview).

P2888

P304

319-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPURO1124

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5392124

http://www.w3.org/2001/XMLSchema#string

P698

18461049

http://www.w3.org/2001/XMLSchema#string

P932

3119263

http://www.w3.org/2001/XMLSchema#string